De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Cooper Companies Beheer
Beheer criteriumcontroles 4/4
De CEO Cooper Companies' is Al White, benoemd in May2018, heeft een ambtstermijn van 6.42 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 13.49M, bestaande uit 7.8% salaris en 92.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.083% van de aandelen van het bedrijf, ter waarde $ 18.24M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 6.7 jaar en 5.2 jaar.
Belangrijke informatie
Al White
Algemeen directeur
US$13.5m
Totale compensatie
| Percentage CEO-salaris | 7.8% |
| Dienstverband CEO | 6.4yrs |
| Eigendom CEO | 0.08% |
| Management gemiddelde ambtstermijn | 6.7yrs |
| Gemiddelde ambtstermijn bestuur | 5.2yrs |
Recente managementupdates
Recent updates
Are Investors Undervaluing The Cooper Companies, Inc. (NASDAQ:COO) By 35%?
Oct 01
Returns On Capital At Cooper Companies (NASDAQ:COO) Paint A Concerning Picture
Sep 15The Cooper Companies: Still An Expensive Place
Aug 26Investors Interested In The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings
Aug 17Is There Now An Opportunity In The Cooper Companies, Inc. (NASDAQ:COO)?
Jul 30Is There An Opportunity With The Cooper Companies, Inc.'s (NASDAQ:COO) 36% Undervaluation?
Jun 20Cooper Companies: Business Growth Noted, Valuations An Ask
Jun 14Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
May 21With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
May 02Should You Think About Buying The Cooper Companies, Inc. (NASDAQ:COO) Now?
Apr 17The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue
Mar 22Calculating The Intrinsic Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Mar 18The Cooper Companies: I Still Don't See Much Upside
Mar 01These 4 Measures Indicate That Cooper Companies (NASDAQ:COO) Is Using Debt Reasonably Well
Jan 23Cooper Companies: Women Health Business Makes Room For Growth; Path For Margin Expansion
Jan 15When Should You Buy The Cooper Companies, Inc. (NASDAQ:COO)?
Jan 08With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
Dec 24A Look At The Fair Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Nov 30Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
Oct 30What Does The Cooper Companies, Inc.'s (NASDAQ:COO) Share Price Indicate?
Sep 28Cooper Offers A Great Business But A Somewhat Tricky Valuation
Sep 25Here's Why Cooper Companies (NYSE:COO) Can Manage Its Debt Responsibly
Sep 10Calculating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Aug 23Cooper Companies (NYSE:COO) Is Reinvesting At Lower Rates Of Return
Jul 24The Cooper Companies: Valuation Is Too High (Rating Downgrade)
Jul 12When Should You Buy The Cooper Companies, Inc. (NYSE:COO)?
Jun 24Is Cooper Companies (NYSE:COO) Using Too Much Debt?
Jun 08Estimating The Intrinsic Value Of The Cooper Companies, Inc. (NYSE:COO)
May 24Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Apr 23At US$355, Is The Cooper Companies, Inc. (NYSE:COO) Worth Looking At Closely?
Mar 25These 4 Measures Indicate That Cooper Companies (NYSE:COO) Is Using Debt Reasonably Well
Feb 04Cooper Companies: Growth Comes At A High Cost To Equity Holders, Rate Hold
Jan 30Estimating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Jan 19Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Jan 04Cooper Cos. initiated at buy at Mizuho on contact lenses, cataract implants positioning
Dec 22Is It Too Late To Consider Buying The Cooper Companies, Inc. (NYSE:COO)?
Dec 20The Cooper Companies declares $0.03 dividend
Dec 14The Cooper Companies Non-GAAP EPS of $2.75 misses by $0.36, revenue of $848.1M beats by $9.22M
Dec 08Cooper Companies: Questions On Viability Of Future Earnings Upside
Nov 04Are Investors Undervaluing The Cooper Companies, Inc. (NYSE:COO) By 38%?
Oct 18BioSkryb, Cooper ink license deal for genomic technology for women's reproductive health
Oct 18Be Wary Of Cooper Companies (NYSE:COO) And Its Returns On Capital
Oct 03Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jul 31 2024 | n/a | n/a | US$359m |
| Apr 30 2024 | n/a | n/a | US$340m |
| Jan 31 2024 | n/a | n/a | US$291m |
| Oct 31 2023 | US$13m | US$1m | US$294m |
| Jul 31 2023 | n/a | n/a | US$275m |
| Apr 30 2023 | n/a | n/a | US$288m |
| Jan 31 2023 | n/a | n/a | US$375m |
| Oct 31 2022 | US$12m | US$925k | US$386m |
| Jul 31 2022 | n/a | n/a | US$431m |
| Apr 30 2022 | n/a | n/a | US$948m |
| Jan 31 2022 | n/a | n/a | US$939m |
| Oct 31 2021 | US$11m | US$925k | US$3b |
| Jul 31 2021 | n/a | n/a | US$3b |
| Apr 30 2021 | n/a | n/a | US$2b |
| Jan 31 2021 | n/a | n/a | US$2b |
| Oct 31 2020 | US$10m | US$925k | US$238m |
| Jul 31 2020 | n/a | n/a | US$278m |
| Apr 30 2020 | n/a | n/a | US$343m |
| Jan 31 2020 | n/a | n/a | US$454m |
| Oct 31 2019 | US$8m | US$925k | US$467m |
| Jul 31 2019 | n/a | n/a | US$446m |
| Apr 30 2019 | n/a | n/a | US$427m |
| Jan 31 2019 | n/a | n/a | US$366m |
| Oct 31 2018 | US$6m | US$689k | US$140m |
| Jul 31 2018 | n/a | n/a | US$128m |
| Apr 30 2018 | n/a | n/a | US$131m |
| Jan 31 2018 | n/a | n/a | US$175m |
| Oct 31 2017 | US$3m | US$525k | US$373m |
Compensatie versus markt: De totale vergoeding ($USD 13.49M ) Al } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 13.04M ).
Compensatie versus inkomsten: De vergoeding van Al is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Al White (54 yo)
6.4yrs
Tenure
US$13,490,923
Compensatie
Mr. Albert G. White, III, also known as Al, serves as Independent Director of Evolus, Inc. since July 1, 2024. He has been President and Chief Executive Officer of The Cooper Companies, Inc. since May 1, 2...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 6.4yrs | US$13.49m | 0.083% $ 17.5m | |
| Executive VP | 11.8yrs | US$3.47m | 0.0080% $ 1.7m | |
| Executive VP & COO | 10.9yrs | US$4.38m | 0.070% $ 14.7m | |
| President of CooperSurgical | 4.3yrs | US$3.22m | 0.012% $ 2.5m | |
| President of CooperVision | 2.7yrs | US$2.78m | 0.0026% $ 546.3k | |
| Senior VP & Chief Accounting Officer | 7yrs | US$1.77m | 0.0024% $ 510.5k | |
| Vice President of Investor Relations & Risk Management | 9.9yrs | geen gegevens | geen gegevens | |
| General Counsel & Corporate Secretary | 2.2yrs | geen gegevens | 0.00034% $ 71.7k |
6.7yrs
Gemiddelde duur
54yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van COO is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.7 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 6.6yrs | US$13.49m | 0.083% $ 17.5m | |
| Independent Chairman of the Board | 28.8yrs | US$471.82k | 0.28% $ 58.4m | |
| Independent Director | 3.8yrs | US$344.94k | 0.0048% $ 1.0m | |
| Independent Vice Chairman & Lead Director | 8.5yrs | US$368.38k | 0.014% $ 3.0m | |
| Independent Director | less than a year | geen gegevens | 0.00053% $ 111.8k | |
| Independent Director | 2yrs | US$311.61k | 0.0025% $ 523.1k | |
| Independent Director | 8.5yrs | US$339.94k | 0.013% $ 2.8m | |
| Independent Director | 3.3yrs | US$319.94k | 0.0037% $ 786.8k |
5.2yrs
Gemiddelde duur
65yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van COO wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.2 jaar).